AGTC - Applied Genetic Technologies Corporation
| Previous Close | 6.88 |
| Open | 6.76 |
| Bid | 6.81 x 1100 |
| Ask | 6.84 x 800 |
| Day's Range | 6.75 - 6.99 |
| 52 Week Range | 3.45 - 7.50 |
| Volume | 27,513 |
| Avg. Volume | 163,321 |
| Market Cap | 123.674M |
| Beta (3Y Monthly) | 2.89 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.03 |
| Earnings Date | Feb 6, 2018 - Feb 12, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.60 |
- GlobeNewswire•5 days ago
Consolidated Research: 2018 Summary Expectations for Tapestry, Mallinckrodt public limited company, Moxian, Applied Genetic Technologies, VistaGen Therapeutics, and Oasis Midstream Partners LP — Fundamental Analysis, Key Performance Indications
NEW YORK, Nov. 15, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Thomson Reuters StreetEvents•10 days ago
Edited Transcript of AGTC earnings conference call or presentation 8-Nov-18 1:00pm GMT
Q1 2019 Applied Genetic Technologies Corp Earnings Call
- Zacks•12 days ago
Applied Genetic Technologies (AGTC) Tops Q1 Earnings and Revenue Estimates
Applied Genetic Technologies (AGTC) delivered earnings and revenue surprises of 114.00% and 383.93%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•12 days ago
Applied Genetic Technologies: Fiscal 1Q Earnings Snapshot
On a per-share basis, the Alachua, Florida-based company said it had net income of 7 cents. The biotechnology company posted revenue of $14 million in the period. Applied Genetic Technologies shares have ...
- GlobeNewswire•12 days ago
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 08, 2018 -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of.
- GlobeNewswire•19 days ago
AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 8, 2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 01, 2018 -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of.
- Zacks•21 days ago
Earnings Preview: Applied Genetic Technologies (AGTC) Q1 Earnings Expected to Decline
Applied Genetic Technologies (AGTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire•2 months ago
AGTC to Present at Upcoming Conferences
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 27, 2018-- Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus- based gene therapies ...
- GlobeNewswire•2 months ago
AGTC Appoints William Aliski to its Board of Directors
Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced it has appointed William Aliski to the company’s Board of Directors. “Bill will be an invaluable addition to the AGTC Board of Directors and leadership team,” said Sue Washer, President and CEO of AGTC.
- Benzinga•2 months ago
Wells Fargo Bullish On Applied Genetic Technologies Ahead Of Program Update
The bullish case for Applied Genetic Technologies Corp (NASDAQ: AGTC ), a nano-cap biotech conducting human clinical trials of adeno-associated virus-based gene therapies, can be made on the basis of an ...
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of AGTC earnings conference call or presentation 10-Sep-18 8:30pm GMT
Q4 2018 Applied Genetic Technologies Corp Earnings Call
- GuruFocus.com•2 months ago
Applied Genetic Technologies Corp (AGTC) Files 10-K for the Fiscal Year Ended on June 30, 2018
Warning! GuruFocus has detected 2 Warning Signs with AGTC. For the last quarter Applied Genetic Technologies Corp reported a revenue of $3.60 million, compared with the revenue of $8.39 million during the same period a year ago. The Applied Genetic Technologies Corp had an operating margin of -92.55%, compared with the operating margin of 4.82% a year before.
- Associated Press•2 months ago
Applied Genetic Technologies: Fiscal 4Q Earnings Snapshot
The Alachua, Florida-based company said it had a loss of 37 cents per share. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
- GlobeNewswire•2 months ago
AGTC Announces Financial Results and Business Update for the Fourth Quarter and Fiscal Year Ended June 30, 2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 10, 2018-- Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus- based gene therapies ...
- Benzinga•2 months ago
Earnings Outlook for Applied Genetic Tech
Applied Genetic Tech (NASDAQ: AGTC ) announces its next round of earnings Monday, Sept. 10. Here is Benzinga's everything-that-matters guide for today's Q4 earnings announcement. Earnings, Revenue Based ...
- GlobeNewswire•3 months ago
AGTC to Host Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast on September 10, 2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 30, 2018-- Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus- based gene therapies ...
- Thomson Reuters StreetEvents•6 months ago
Edited Transcript of AGTC earnings conference call or presentation 8-May-18 8:30pm GMT
Q3 2018 Applied Genetic Technologies Corp Earnings Call
- Associated Press•6 months ago
Applied Genetic Technologies: Fiscal 3Q Earnings Snapshot
The Alachua, Florida-based company said it had a loss of 45 cents per share. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
